Share Price and Basic Stock Data
Last Updated: November 14, 2025, 10:49 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Abate As Industries Ltd operates within the Non-Banking Financial Company (NBFC) sector, reporting a market capitalization of ₹266 Cr and a current share price of ₹16.9. The company has shown stagnant sales performance, with reported sales standing at ₹0.00 for each quarter from June 2022 through June 2024, indicating a lack of operational revenue generation. This trend extends to the trailing twelve months (TTM), where total sales remained at ₹0.00. The absence of sales suggests challenges in business activities or potential strategic shifts away from revenue generation. However, the company has recorded other income, which rose to ₹0.97 Cr in the fiscal year ending March 2025, contributing to a modest financial inflow despite the lack of operational sales. Over the years, expenses have fluctuated, with a reported high of ₹0.90 Cr in March 2024, reflecting the company’s ongoing operational costs despite no revenue generation. This trend raises concerns about the sustainability of the company’s financial health.
Profitability and Efficiency Metrics
Abate As Industries Ltd has consistently reported net losses across multiple fiscal periods, with a net profit of -₹1.58 Cr for the current financial year. The operating profit margin (OPM) has not been available, given the lack of operational revenue; however, the company reported negative operating profits, peaking at -₹2.29 Cr in December 2024. The interest coverage ratio stood at a robust 28.95x, indicating that the company can comfortably meet its interest obligations despite the negative profitability. The return on equity (ROE) and return on capital employed (ROCE) were reported at 0.66% and 0.65%, respectively, suggesting minimal returns relative to equity and capital investments. The company’s profitability metrics are significantly below industry norms, highlighting operational inefficiencies and the necessity for strategic realignment to enhance financial performance and profitability in the forthcoming periods.
Balance Sheet Strength and Financial Ratios
The balance sheet of Abate As Industries Ltd reveals a total asset base of ₹165.79 Cr and total liabilities of ₹165.79 Cr, implying a balanced asset-liability structure with no net worth, as the company’s reserves stood at ₹85.24 Cr against borrowings of ₹1.58 Cr. The price-to-book value ratio is recorded at 0.92x, suggesting the stock is trading below its book value, which may indicate undervaluation in the market. The current ratio of 2.66x and quick ratio of 1.88x reflect strong liquidity positions, indicating the company can meet its short-term obligations effectively. Additionally, the financial ratios depict a low long-term debt-to-equity ratio of 0.02x and a total debt-to-equity ratio of 0.06x, showcasing minimal leverage and lower financial risk. However, the reliance on borrowed funds remains low, which can limit growth opportunities if the company decides to pursue expansion or operational enhancements.
Shareholding Pattern and Investor Confidence
The shareholding structure of Abate As Industries Ltd indicates that promoters hold 27.57% of the company, down from 31.87% earlier in the fiscal year, suggesting a gradual decline in promoter confidence. The public holds a substantial 72.43% stake, which reflects a broad base of retail investors. The number of shareholders surged to 2,272 by August 2025, indicating growing interest or confidence from the investing community despite the company’s ongoing challenges. The lack of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) may suggest limited institutional backing, which could impact liquidity and share price stability. The increasing number of retail shareholders may provide some support to the stock, but the declining promoter stake raises concerns about the long-term strategic direction of the company. Investor sentiment may hinge on the company’s ability to turn around its operational performance and profitability.
Outlook, Risks, and Final Insight
Given the current financial standing of Abate As Industries Ltd, the outlook remains cautious. The company must address its operational inefficiencies to generate revenue and achieve profitability. The absence of sales and consistent net losses are significant risks that could deter potential investors and affect the stock’s performance. However, the strong liquidity position and low leverage offer a buffer against immediate financial distress. Strategic initiatives aimed at diversifying revenue streams or restructuring operations could provide pathways to recovery. The gradual decline in promoter shareholding may also signal internal concerns about the company’s future direction. If Abate As Industries can successfully pivot and leverage its financial strengths, it may enhance investor confidence and operational viability. Conversely, failure to address these operational challenges could lead to prolonged financial instability, impacting shareholder value significantly.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Abate As Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 11.3 Cr. | 1.13 | 1.91/0.89 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 11.3 Cr. | 1.13 | 11.5/1.03 | 33.4 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 472 Cr. | 144 | 269/130 | 80.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 15.1 Cr. | 16.5 | 37.9/15.0 | 11.3 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 43.9 Cr. | 97.5 | 180/90.0 | 23.4 | 238 | 1.03 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 28,434.70 Cr | 472.90 | 112.86 | 518.50 | 0.21% | 15.80% | 8.84% | 8.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.08 | 0.07 | 0.06 | 0.17 | 0.05 | 0.05 | 0.02 | 0.16 | 0.04 | 0.03 | 2.29 | 0.34 | 0.27 |
| Operating Profit | -0.08 | -0.07 | -0.06 | -0.17 | -0.05 | -0.05 | -0.02 | -0.16 | -0.04 | -0.03 | -2.29 | -0.34 | -0.27 |
| OPM % | |||||||||||||
| Other Income | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.97 | 0.40 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Profit before tax | -0.08 | -0.07 | -0.06 | -0.15 | -0.05 | -0.05 | -0.02 | -0.16 | -0.04 | -0.03 | -2.31 | 0.63 | 0.13 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.08 | -0.07 | -0.06 | -0.15 | -0.05 | -0.05 | -0.02 | -0.16 | -0.04 | -0.03 | -2.31 | 0.63 | 0.13 |
| EPS in Rs | -0.08 | -0.07 | -0.06 | -0.15 | -0.05 | -0.05 | -0.02 | -0.16 | -0.04 | -0.03 | -2.31 | 0.04 | 0.01 |
Last Updated: August 20, 2025, 12:45 am
Below is a detailed analysis of the quarterly data for Abate As Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.27 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.34 Cr. (Mar 2025) to 0.27 Cr., marking a decrease of 0.07 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.27 Cr.. The value appears strong and on an upward trend. It has increased from -0.34 Cr. (Mar 2025) to -0.27 Cr., marking an increase of 0.07 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 0.40 Cr.. The value appears to be declining and may need further review. It has decreased from 0.97 Cr. (Mar 2025) to 0.40 Cr., marking a decrease of 0.57 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.13 Cr.. The value appears to be declining and may need further review. It has decreased from 0.63 Cr. (Mar 2025) to 0.13 Cr., marking a decrease of 0.50 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is 0.13 Cr.. The value appears to be declining and may need further review. It has decreased from 0.63 Cr. (Mar 2025) to 0.13 Cr., marking a decrease of 0.50 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.01. The value appears to be declining and may need further review. It has decreased from 0.04 (Mar 2025) to 0.01, marking a decrease of 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:05 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.08 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | -0.01 | 0.00 | 0.00 |
| Expenses | 0.07 | 0.08 | 0.07 | 0.09 | 0.07 | 0.10 | 0.12 | 0.13 | 0.57 | 0.33 | 0.90 | 0.43 | 3.01 |
| Operating Profit | 0.01 | 0.01 | -0.07 | -0.09 | -0.07 | -0.10 | -0.12 | -0.13 | -0.58 | -0.35 | -0.91 | -0.43 | -3.01 |
| OPM % | 12.50% | 11.11% | |||||||||||
| Other Income | 0.00 | 0.00 | -4.77 | 0.08 | 0.05 | 0.11 | 0.15 | 0.14 | 0.17 | 0.00 | 0.00 | 0.97 | 2.32 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Profit before tax | 0.00 | 0.00 | -4.85 | -0.02 | -0.02 | 0.00 | 0.02 | 0.01 | -0.42 | -0.35 | -0.91 | 0.54 | -0.71 |
| Tax % | 0.00% | 0.00% | 0.00% | -50.00% | 0.00% | -19.05% | 0.00% | 0.00% | 0.00% | ||||
| Net Profit | 0.00 | 0.00 | -4.84 | -0.01 | -0.02 | 0.00 | 0.02 | 0.01 | -0.34 | -0.35 | -0.91 | 0.54 | -0.71 |
| EPS in Rs | 0.00 | 0.00 | -4.84 | -0.01 | -0.02 | 0.00 | 0.02 | 0.01 | -0.34 | -0.35 | -0.91 | 0.03 | -2.21 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 99.79% | -100.00% | 100.00% | -50.00% | -3500.00% | -2.94% | -160.00% | 159.34% |
| Change in YoY Net Profit Growth (%) | 0.00% | -199.79% | 200.00% | -150.00% | -3450.00% | 3497.06% | -157.06% | 319.34% |
Abate As Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 93% |
| 3 Years: | 53% |
| TTM: | -485% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 42% |
| 5 Years: | 73% |
| 3 Years: | 44% |
| 1 Year: | 68% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 1% |
Last Updated: September 5, 2025, 2:01 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63,875.00 | 56,291.11 | -7,300.00 | -1,460.00 | 0.00 | |||||||
| Inventory Days | 0.00 | 0.00 | 0.00 | |||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 63,875.00 | 56,291.11 | -7,300.00 | -1,460.00 | 0.00 | |||||||
| Working Capital Days | 17,976.25 | 15,816.67 | 4,015.00 | -4,380.00 | -39,420.00 | |||||||
| ROCE % | 0.00% | 0.00% | -2.79% | -3.45% | -2.90% | 0.00% | 3.08% | 1.40% | -59.85% | -57.85% | -191.58% | 0.65% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 10.00 |
| Basic EPS (Rs.) | 0.59 |
| Diluted EPS (Rs.) | 0.59 |
| Cash EPS (Rs.) | 0.21 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 20.79 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 20.79 |
| Revenue From Operations / Share (Rs.) | 1.79 |
| PBDIT / Share (Rs.) | 0.21 |
| PBIT / Share (Rs.) | 0.14 |
| PBT / Share (Rs.) | 0.13 |
| Net Profit / Share (Rs.) | 0.14 |
| NP After MI And SOA / Share (Rs.) | 0.09 |
| PBDIT Margin (%) | 12.11 |
| PBIT Margin (%) | 8.18 |
| PBT Margin (%) | 7.76 |
| Net Profit Margin (%) | 7.87 |
| NP After MI And SOA Margin (%) | 5.05 |
| Return on Networth / Equity (%) | 0.43 |
| Return on Capital Employeed (%) | 0.60 |
| Return On Assets (%) | 0.34 |
| Long Term Debt / Equity (X) | 0.02 |
| Total Debt / Equity (X) | 0.06 |
| Current Ratio (X) | 2.66 |
| Quick Ratio (X) | 1.88 |
| Interest Coverage Ratio (X) | 28.95 |
| Interest Coverage Ratio (Post Tax) (X) | 19.81 |
| Enterprise Value (Cr.) | 182.69 |
| EV / Net Operating Revenue (X) | 12.97 |
| EV / EBITDA (X) | 107.07 |
| MarketCap / Net Operating Revenue (X) | 10.76 |
| Price / BV (X) | 0.92 |
| Price / Net Operating Revenue (X) | 10.77 |
After reviewing the key financial ratios for Abate As Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.79. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.79. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1.79. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 2. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.14. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.13. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 2. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.09. This value is below the healthy minimum of 2. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 12.11. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 8.18. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 7.76. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 7.87. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.05. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 2.66. This value is within the healthy range. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 1.88. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 28.95. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 19.81. This value is within the healthy range. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 182.69. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 12.97. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 107.07. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 10.76. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 10.77. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Abate As Industries Ltd:
- Net Profit Margin: 7.87%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.6% (Industry Average ROCE: 15.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.43% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 19.81
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.88
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 112.86)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.87%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | SF No. 348/1, Ettimadai Village, Coimbatore Tamil Nadu 641105 | abateasindustries@gmail.com https://www.abateas.com |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Adv Arikuzhiyan Samsudeen | Chairman & Non-Exe.Director |
| Dr. Muhemmed Swadique | Whole Time Director |
| Mr. Muhammed Kutty Arikuzhiyil | Non Executive Director |
| Mr. Abdul Nazar Jamal Kizhisseri Muhammed | Non Executive Director |
| Dr. Rajesh Puthussery | Non Executive Director |
| Dr. M A Safarulla | Non Executive Director |
| Ms. Julie G Varghese | Ind. Non-Executive Director |
| Mrs. Indu Ravindran | Ind. Non-Executive Director |
| Mrs. Manjusha Ramakrishnan Puthenpurakkal | Ind. Non-Executive Director |
| Mr. Eramangalath Gopalakrishna Panicker Mohankumar | Non Executive Director |
| Mr. Mohammed Kabeer Moolian | Ind. Non-Executive Director |
| Mr. Pattassery Alavi Haji | Ind. Non-Executive Director |
| Mr. Ali Thonikkadavath | Non Executive Director |